Treatment Of Retinal Degeneration Using Gene Therapy

Patent No. EP3110433 (titled "Treatment Of Retinal Degeneration Using Gene Therapy") was filed by The University OF Manchester on Feb 24, 2015. The application was issued on Feb 22, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRATAGEM INTELLECTUALApr 17, 2020STRATAGEM IPM
STRATAGEMApr 17, 2020STRATAGEM IPM
KELTIEApr 9, 2020CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3110433

THE UNIVERSITY OF MANCHESTER
Application Number
EP15707722A
Filing Date
Feb 24, 2015
Status
Patent Maintained As Amended
Jan 20, 2023
Publication Date
Feb 22, 2023